...
首页> 外文期刊>Computers in Biology and Medicine >DrugR plus : A comprehensive relational database for drug repurposing, combination therapy, and replacement therapy
【24h】

DrugR plus : A comprehensive relational database for drug repurposing, combination therapy, and replacement therapy

机译:Drugr Plus:一种综合关系数据库,用于药物修复,组合治疗和替代疗法

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Drug repurposing or repositioning, which introduces new applications of the existing drugs, is an emerging field in drug discovery scope. To enhance the success rate of the research and development (R&D) process in a cost- and time-effective manner, a number of pharmaceutical companies worldwide have made tremendous investments. Besides, many researchers have proposed various methods and databases for the repurposing of various drugs. However, there is not a proper and well-organized database available. To this end, for the first time, we developed a new database based on DrugBank and KEGG data, which is named "DrugR +". Our developed database provides some advantages relative to the DrugBank, and its interface supplies new capabilities for both single and synthetic repositioning of drugs. Moreover, it includes four new datasets which can be used for predicting drug-target interactions using supervised machine learning methods. As a case study, we introduced novel applications of some drugs and discussed the obtained results. A comparison of several machine learning methods on the generated datasets has also been reported in the Supplementary File. Having included several normalized tables, DrugR + has been organized to provide key information on data structures for the re-purposing and combining applications of drugs. It provides the SQL query capability for professional users and an appropriate method with different options for unprofessional users. Additionally, DrugR + consists of re-purposing service that accepts a drug and proposes a list of potential drugs for some usages. Taken all, DrugR + is a free web-based database and accessible using (http://www.drugr.ir), which can be updated through a map reduce parallel processing method to provide the most relevant information.
机译:介绍现有药物的新应用的药物重估或重新定位是药物发现范围的新兴领域。以成本和有效的方式提高研究与开发(研发)流程的成功率,全球许多制药公司都取得了巨大的投资。此外,许多研究人员提出了用于重新批准各种药物的各种方法和数据库。但是,没有适当且有组织良好的数据库可用。为此,我们首次开发了基于药物银行和Kegg数据的新数据库,该数据被命名为“Drugr +”。我们开发的数据库相对于药物银行提供了一些优点,其界面为单身和合成重新定位提供了新的功能。此外,它包括四个新数据集,可用于使用监督机器学习方法预测药物目标相互作用。作为一个案例研究,我们介绍了一些药物的新型应用,并讨论了所获得的结果。在补充文件中也报告了在生成的数据集上的几种机器学习方法的比较。已经包括多个标准化表,DRUGR +已经组织成提供有关重新缺发和组合药物应用的数据结构的关键信息。它为专业用户提供了SQL查询功能,以及一个适用于不专业用户的不同选项的方法。此外,Drugr +包括接受药物的重新播放服务,并提出了一些潜在药物的一些用途。拿走了Drugr +是一个免费的基于Web的数据库,可以使用(http://www.drugr.ir),它可以通过地图更新,这将减少并行处理方法提供最相关的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号